147 related articles for article (PubMed ID: 36462224)
1. Serum C3 complement levels predict prognosis and monitor disease activity in Guillain-Barré syndrome.
Min YG; Ju W; Seo JW; Ha YE; Ban JJ; Kwon YN; Jeong HY; Shin JY; Kim SM; Hong YH; Kim SJ; Sung JJ
J Neurol Sci; 2023 Jan; 444():120512. PubMed ID: 36462224
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy and mechanism of lymphoplasma exchange in the treatment of Guillain-Barre syndrome.
Luo MC; Wang WF; Yin WF; Li Y; Li BJ; Duan WW; Zeng QM; Luo YB; Yang XS; Yang H
Cell Mol Biol (Noisy-le-grand); 2017 Oct; 63(10):106-115. PubMed ID: 29096750
[TBL] [Abstract][Full Text] [Related]
3. Correlation of Cerebrospinal Fluid Total Protein and Serum Neutrophil-to-Lymphocyte Ratio with Clinical Outcomes of Guillain-Barre Syndrome Variants.
Bano S; Nawaz A; Nasim A; Numan A; Zahid M
J Coll Physicians Surg Pak; 2024 Feb; 34(2):187-192. PubMed ID: 38342870
[TBL] [Abstract][Full Text] [Related]
4. Association of Albumin Levels With Outcome in Intravenous Immunoglobulin-Treated Guillain-Barré Syndrome.
Fokkink WR; Walgaard C; Kuitwaard K; Tio-Gillen AP; van Doorn PA; Jacobs BC
JAMA Neurol; 2017 Feb; 74(2):189-196. PubMed ID: 28027337
[TBL] [Abstract][Full Text] [Related]
5. The prediction effects of thyroid function in the severity of Guillain-Barré syndrome.
Kong L; Wu X; Cheng Y; Liu S; Liu K; Li C
Neurol Sci; 2022 Aug; 43(8):5017-5028. PubMed ID: 35469074
[TBL] [Abstract][Full Text] [Related]
6. The utility of Guillain-Barré syndrome prognostic models in Malaysian patients.
Tan CY; Razali SNO; Goh KJ; Shahrizaila N
J Peripher Nerv Syst; 2019 Jun; 24(2):168-173. PubMed ID: 31001904
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic factors in Guillain-Barré syndrome].
Kaida K
Rinsho Shinkeigaku; 2013; 53(11):1315-8. PubMed ID: 24291972
[TBL] [Abstract][Full Text] [Related]
8. The usefulness of chief complaints to predict severity, ventilator dependence, treatment option, and short-term outcome of patients with Guillain-Barré syndrome: a retrospective study.
Wang Y; Shang P; Xin M; Bai J; Zhou C; Zhang HL
BMC Neurol; 2017 Nov; 17(1):200. PubMed ID: 29157205
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil-lymphocyte ratio in Guillain-Barré syndrome: A prognostic biomarker of severe disease and mechanical ventilation in Bangladesh.
Jahan I; Ahmed R; Ahmed J; Khurshid S; Biswas PP; Upama IJ; Hamid Y; Papri N; Islam Z
J Peripher Nerv Syst; 2023 Mar; 28(1):47-57. PubMed ID: 36700342
[TBL] [Abstract][Full Text] [Related]
10. Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial.
Walgaard C; Jacobs BC; Lingsma HF; Steyerberg EW; Cornblath DR; van Doorn PA;
J Peripher Nerv Syst; 2018 Dec; 23(4):210-215. PubMed ID: 30151941
[TBL] [Abstract][Full Text] [Related]
11. Early predictors of functional disability in Guillain-Barré Syndrome.
Tunç A
Acta Neurol Belg; 2019 Dec; 119(4):555-559. PubMed ID: 30963477
[TBL] [Abstract][Full Text] [Related]
12. Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study.
Verboon C; van den Berg B; Cornblath DR; Venema E; Gorson KC; Lunn MP; Lingsma H; Van den Bergh P; Harbo T; Bateman K; Pereon Y; Sindrup SH; Kusunoki S; Miller J; Islam Z; Hartung HP; Chavada G; Jacobs BC; Hughes RAC; van Doorn PA;
J Neurol Neurosurg Psychiatry; 2020 Feb; 91(2):113-121. PubMed ID: 31586949
[TBL] [Abstract][Full Text] [Related]
13. International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome.
Jacobs BC; van den Berg B; Verboon C; Chavada G; Cornblath DR; Gorson KC; Harbo T; Hartung HP; Hughes RAC; Kusunoki S; van Doorn PA; Willison HJ;
J Peripher Nerv Syst; 2017 Jun; 22(2):68-76. PubMed ID: 28406555
[TBL] [Abstract][Full Text] [Related]
14. Role of lymphocyte-related immune-inflammatory biomarkers in detecting early progression of Guillain-Barré syndrome.
Xu L; Gao TX; Chang SH; Jiang SM; Zhang LJ; Yang L
J Clin Neurosci; 2022 Nov; 105():31-36. PubMed ID: 36063751
[TBL] [Abstract][Full Text] [Related]
15. Guillain-Barré syndrome: activated complement components C3a and C5a in CSF.
Hartung HP; Schwenke C; Bitter-Suermann D; Toyka KV
Neurology; 1987 Jun; 37(6):1006-9. PubMed ID: 3495747
[TBL] [Abstract][Full Text] [Related]
16. Predicting of Mechanical Ventilation and Outcomes by Using Models and Biomarker in Guillain-Barré Syndrome.
Yao J; Zhou R; Liu Y; Liu Y; Cao Q; Lu Z
Neurol Ther; 2023 Dec; 12(6):2121-2132. PubMed ID: 37792219
[TBL] [Abstract][Full Text] [Related]
17. Serum Folate Correlates with Severity of Guillain-Barré Syndrome and Predicts Disease Progression.
Gao Y; Zhang HL; Xin M; Wang D; Zheng N; Wang S; Xu J; Wang Y; Zhu J; Feng J
Biomed Res Int; 2018; 2018():5703279. PubMed ID: 30013984
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
Manzi S; Rairie JE; Carpenter AB; Kelly RH; Jagarlapudi SP; Sereika SM; Medsger TA; Ramsey-Goldman R
Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328
[TBL] [Abstract][Full Text] [Related]
19. Increased serum neurofilament light chain concentration indicates poor outcome in Guillain-Barré syndrome.
Altmann P; De Simoni D; Kaider A; Ludwig B; Rath J; Leutmezer F; Zimprich F; Hoeftberger R; Lunn MP; Heslegrave A; Berger T; Zetterberg H; Rommer PS
J Neuroinflammation; 2020 Mar; 17(1):86. PubMed ID: 32183837
[TBL] [Abstract][Full Text] [Related]
20. Association between serum low-density neutrophils and acute-onset and recurrent Guillain-Barré syndrome.
Ren K; Yang A; Lu J; Zhao D; Bai M; Ding J; Wei T; Li H; Guo J
Brain Behav; 2022 Jan; 12(1):e2456. PubMed ID: 34894104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
